News

Proposal for FET Flagship on Biofabrication for Regenerative Medicine

- This FET Flagship proposal contains a statement on the clustering of health topics in biofabrication for regenerative medicine. Related to the following topics: Human Printing Era (HOPE), organ-on-chip technology, European initiative for regenerative medicine, and sensory restoration.

Report on joint Human Capital Agenda 2016-2020

- The report illustrates the results and collaboration between the nine different top sectors.

Dutch Healthcare system higly ranked in International Health Policy Survey

- Amerikaanse denktank The Commonwalth Fund (CWF) legt Westerse landen langs de meetlat. En wederom scoort de Nederlandse zorg hoog in een internationaal onderzoek.

Lygature opens new office at Utrecht Innovation hub

- Vandaag opent Lygature haar nieuwe werkomgeving in Utrecht. Lygature, het resultaat van de fusie tussen CTMM en TI Pharma, is de eerste bewoner van de JIM: de Jaarbeurs Innovation Mile. De opening wordt verzorgd door de burgemeester van Utrecht, Jan van Zanen, en David Pappie, directeur topsectoren van het Ministerie van Economische Zaken.

MyLife Technologies secures new growth capital

- A consortium of informal investors has invested 0.5 million € in MyLife Technologies, a med tech company developing dermal delivery solutions based on its platform technology of ceramic nano-porous MicroNeedle Arrays (npMNA).

AdAlta Licenses Alzheimer's Disease-Specific Shark Antibodies to Crossbeta Biosciences for Therapeutic and Diagnostic Development

- AdAlta Limited, a biotechnology company specialising in the discovery and development of protein-based therapeutics, and Crossbeta Biosciences, a biotechnology company with unique technology for therapeutic and diagnostic use in neurodegenerative disorders, announced their commercialisation agreement.

Mucosis Initiates First-in-Human Study of SynGEM, a Needle-Free Nasal Spray RSV Vaccine

- Mucosis, a clinical stage biotechnology company using a proprietary technology platform to develop next-generation and needle-free human vaccines for infectious diseases, announces the start of a first-in-human study of its intranasal Respiratory Syncytial Virus (RSV) vaccine candidate, SynGEM, at Imperial College London’s Clinical Research Facility.

Create Health at Drive Festival: Partnerships in design and healthcare

- Hoe creëer je zorginnovaties met impact? Lees hier het verslag naar van het Drive Festival waar Create Health presenteerde over partnerschappen in design en healthcare.

Pink Ribbon and KWF join forces

- De stichtingen Pink Ribbon en KWF Kankerbestrijding voegen vanaf vandaag de bedrijfsvoering samen met als doel een substantiële groei van inkomsten te realiseren voor borstkankeronderzoek. Het merk en de identiteit van Pink Ribbon blijven in deze samenwerking behouden.

Agendia Expands its Business Activities in Germany

- Agendia, a world leader in personalized medicine and molecular cancer diagnostics, announces the expansion of its business activities in Germany. The Company has launched the “BRIDGE” patient initiative to enable more physicians and their patients to access the additional benefits of its MammaPrint test.